PTGS2 and urinary bladder carcinoma: We further investigated the effect of two RTKIs, AB1010 and imatinib, in four COX-2-expressing bladder cancer cell lines (5637, TCCSUP, K9TCC#1Lillie, and K9TCC#5Lilly).